Dalteparin
Links shared publicly online about this topic
No DVT Advantage for Dalteparin (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Use of the low molecular weight heparin dalteparin was not found to be superior to unfractionated heparin for preventing deep vein thrombosis in critically ill patients, according to a multicenter study.” View full resource at qualitypointtech.net
Most Recently Shared on March 23, 2011 at 7:35 pm By:
No DVT Advantage for Dalteparin (CME/CE): (MedPage Today) -- Use of the low molecular weight heparin dalteparin wa... http://bit.ly/g1fxap
Dalteparin No Better Than Unfractionated Heparin for Preventing DVT : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on March 22, 2011 at 6:15 pm By:
Bob Finn - Medical News Net Health News
Dalteparin no better than unfractionated heparin for deep vein thrombosis prevention. Mary Ann Moon reports. http://bit.ly/hBsmD4
Medical News: No DVT Advantage for Dalteparin - in Critical Care, General Critical Care from MedPage Today
medpagetoday.com — “Use of the low molecular weight heparin dalteparin was not found to be superior to unfractionated heparin for preventing deep vein thrombosis in critically ill patients, according to a multicenter stu” View full resource at medpagetoday.com
Most Recently Shared on March 24, 2011 at 10:00 am By:
Hisham Rana, MD Doctor and Physician
Study: No DVT advantage for dalteparin (NEJM) http://bit.ly/hpzUAB - #health
Medical News: No DVT Advantage for Dalteparin - in Critical Care, General Critical Care from MedPage Today
medpagetoday.com — “Use of the low molecular weight heparin dalteparin was not found to be superior to unfractionated heparin for preventing deep vein thrombosis in critically ill patients, according to a multicenter stu” View full resource at medpagetoday.com
Most Recently Shared on March 23, 2011 at 7:32 pm By:
No DVT Advantage for Dalteparin (CME/CE): (MedPage Today) -- Use of the low molecular weight… http://goo.gl/fb/rdsZv
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo - NORRBY - 2010 - APMIS - Wiley Online Library
onlinelibrary.wiley.com — “Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo - NORRBY - 2010 - APMIS - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on November 19, 2010 at 8:50 pm By:
Wiley Health Medical Health Site
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo: Read freely http://ow.ly/3cGsT
VTE prophylaxis in ICU patients | Hospital Medicine Quick Hits
blogs.hospitalmedicine.org — “VTE prophylaxis in ICU patients | Hospital Medicine Quick Hits” View full resource at blogs.hospitalmedicine.org
Most Recently Shared on March 24, 2011 at 7:05 pm By:
Wiley Health Medical Health Site
VTE prophylaxis in ICU patients: In this randomized trial of ICU patients, they were given Dalteparin (5000 IU S... http://bit.ly/fn69kZ
Fragmin (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “How long after your last dose does Fragmin have blood thinnning effects ... Learn about and discuss Fragmin at The People's Medicine Community. (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on August 13, 2011 at 4:05 am By:
" How long after your last dose does Fragmin have blood thinnning effects" http://t.co/JzPeBVy
Drug may help sickest patients
physorg.com — “(PhysOrg.com) -- Patients in critical care have a larger risk for dangerous blood clots because they are immobile and usually have heart or breathing problems. However, an international study by McMaster University researchers has found promise in a lower dose formula of the blood-thinning drug dalteparin.” View full resource at physorg.com
Most Recently Shared on April 15, 2011 at 12:11 pm By:
PhysOrg Health News Health News
Drug may help sickest patients http://tw.physorg.com/222073275
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
-
Hisham Rana, MD
I tweet mostly about medicine, politics, and tech. Please see the link for a disclaimer and other policies.
Advertisement
